July 17, 2018 - The article, "Effective Use of BMS Ruling to Halt Discovery Against Pharma, Medical Device Firms," by Diane Lifton and Julie Amadeo, was published in Bloomberg Law.

In June 2017, in Bristol-Myers Squibb Co. v. Superior Court of California, 137 S.Ct. 1773 (2017) (BMS), the U.S. Supreme Court held that out–of-state plaintiffs cannot compel a company to litigate in a forum where the defendant is not “at home” and the plaintiff’s claims bear little or no connection to the company’s activities in that forum. Plaintiffs have since attempted to prove personal jurisdictional over pharmaceutical and medical device companies by claiming that conducting clinical trials and general marketing of a drug or medical device in that forum create the necessary nexus with a plaintiff’s claims for personal injuries in connection with use of that drug or medical device.

Click here to view the full article.